MARCHETTI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 1.970
EU - Europa 955
AS - Asia 831
SA - Sud America 139
Continente sconosciuto - Info sul continente non disponibili 51
AF - Africa 12
OC - Oceania 2
Totale 3.960
Nazione #
US - Stati Uniti d'America 1.911
SG - Singapore 420
RU - Federazione Russa 257
IE - Irlanda 224
IT - Italia 162
CN - Cina 137
BR - Brasile 118
VN - Vietnam 94
DE - Germania 93
HK - Hong Kong 73
UA - Ucraina 53
TR - Turchia 35
CA - Canada 33
GB - Regno Unito 31
SE - Svezia 30
FI - Finlandia 21
FR - Francia 19
CZ - Repubblica Ceca 18
BE - Belgio 17
IN - India 14
MX - Messico 14
JP - Giappone 13
BD - Bangladesh 11
IQ - Iraq 9
PL - Polonia 8
ZA - Sudafrica 6
AR - Argentina 5
ES - Italia 5
HN - Honduras 5
JO - Giordania 5
RO - Romania 5
CL - Cile 4
CO - Colombia 4
EC - Ecuador 4
LT - Lituania 3
MA - Marocco 3
NL - Olanda 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BG - Bulgaria 2
BH - Bahrain 2
EG - Egitto 2
ID - Indonesia 2
JM - Giamaica 2
KZ - Kazakistan 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
UY - Uruguay 2
AU - Australia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
IL - Israele 1
LB - Libano 1
LY - Libia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 3.910
Città #
Dublin 224
San Jose 221
Singapore 220
Chandler 208
Dallas 206
Jacksonville 173
Ashburn 157
New York 75
Santa Clara 73
Hong Kong 72
Council Bluffs 65
Ann Arbor 53
Boardman 48
The Dalles 46
Beijing 42
Ho Chi Minh City 35
Munich 32
Lawrence 29
Princeton 29
Los Angeles 28
Moscow 24
Izmir 23
Milan 23
Wilmington 20
Brno 18
Brussels 17
São Paulo 14
Tokyo 13
Bremen 12
Dong Ket 12
Helsinki 12
Hanoi 11
Orem 11
Rome 11
Columbus 10
Dearborn 10
Houston 10
Seattle 10
Montreal 9
Assago 8
Atlanta 8
Chicago 8
Haiphong 8
Mexico City 8
Naples 8
San Mateo 8
Denver 7
Falkenstein 7
Nanchang 7
San Francisco 7
Shanghai 7
Stockholm 7
Brooklyn 6
Chennai 6
Johannesburg 6
London 6
Nanjing 6
Amman 5
Da Nang 5
Frankfurt am Main 5
Lauterbourg 5
Warsaw 5
Woodbridge 5
Ankara 4
Baghdad 4
Bari 4
Bologna 4
Cagliari 4
Campinas 4
Campo Grande 4
Phoenix 4
Poplar 4
Toronto 4
Turin 4
Turku 4
Amsterdam 3
Avon 3
Belo Horizonte 3
Boston 3
Catania 3
Des Moines 3
Guangzhou 3
Guayaquil 3
Hải Dương 3
Lappeenranta 3
Manchester 3
Miano 3
Ningbo 3
Nuremberg 3
Paris 3
Rio de Janeiro 3
Saint Paul 3
Santiago 3
Taizhou 3
Tianjin 3
Verona 3
Waltham 3
Baotou 2
Cacoal 2
Canary Wharf 2
Totale 2.584
Nome #
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 163
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 162
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index 161
Factors influencing the clinical presentation of breakthrough pain in cancer patients 160
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 160
Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study 153
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 150
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study 150
Evaluation of prognostic factors for survival in transverse colon cancer 143
Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law 142
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors 138
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 136
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 134
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 134
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 133
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 132
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice 128
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey 122
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 118
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: An action plan 118
Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program 113
BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories 113
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 112
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer. 111
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study 110
What cancer patients actually know regarding Medical Cannabis? A cross-sectional survey with a critical analysis of the current attitudes 106
Recidive loco-regionali da carcinoma colo-rettale: risultati a breve termine della perfusione pelvica ipossica. 101
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 99
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results 99
Is it possible to teach pain therapy playing basketball? 80
Integration between oncology and palliative care: Does one size fit all? 79
Totale 3.960
Categoria #
all - tutte 17.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.782


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202297 0 0 0 5 11 0 2 11 10 3 16 39
2022/2023612 37 51 3 80 34 64 0 32 280 4 20 7
2023/2024185 13 12 4 12 15 78 0 7 0 7 7 30
2024/2025714 23 9 44 39 83 49 100 56 185 26 55 45
2025/20261.475 86 133 165 168 182 103 190 59 118 206 47 18
2026/2027386 30 22 117 217 0 0 0 0 0 0 0 0
Totale 3.960